Edition:
United States

NanoCarrier Co Ltd (4571.T)

4571.T on Tokyo Stock Exchange

766JPY
10:29pm EDT
Change (% chg)

¥-20 (-2.54%)
Prev Close
¥786
Open
¥780
Day's High
¥781
Day's Low
¥764
Volume
175,000
Avg. Vol
295,463
52-wk High
¥2,095
52-wk Low
¥753

Latest Key Developments (Source: Significant Developments)

NanoCarrier forms cooperation with TPG Biologics Inc. on joint research
Thursday, 23 Mar 2017 01:14am EDT 

NanoCarrier Co Ltd <4571.T>:Says the co formed cooperation with TPG Biologics Inc., a unit of Taiwan-based firm Center Laboratories Inc.<4123.TWO>, on joint research.  Full Article

NanoCarrier decides to terminate clinical trial of NC-6004
Wednesday, 21 Dec 2016 04:11am EST 

NanoCarrier Co Ltd <4571.T> :Says it decides to terminate the first phase of clinical trial for NC-6004.  Full Article

NanoCarrier says patent for nucleic acid delivery technology granted by European Patent Office
Monday, 1 Aug 2016 12:11am EDT 

NanoCarrier Co Ltd <4571.T>:Says patent related to nucleic acid delivery technology granted by the European Patent Office regarding particle composition and pharmaceutical composition.  Full Article

NanoCarrier says clinical trial of NC-6004
Tuesday, 21 Jun 2016 10:55pm EDT 

NanoCarrier Co Ltd <4571.T>:Says it submitted CTA (Clinical Trial Authorization) of NC-6004 to regulatory authorities of EU regional.  Full Article

NanoCarrier receives patent recognition in U.S
Sunday, 3 Apr 2016 10:30pm EDT 

NanoCarrier Co Ltd:Received patent recognition from United States Patent and Trademark Office, for particle composition as well as its pharmaceutical composition.  Full Article

NanoCarrier enters new development agreement with ALBION
Wednesday, 23 Mar 2016 10:30pm EDT 

NanoCarrier Co Ltd:Enters a new development agreement with ALBION co.,ltd., to cooperate on joint development of products in skin related area.  Full Article

NanoCarrier signs license agreement with Tokyo-based company
Tuesday, 15 Mar 2016 11:35pm EDT 

NanoCarrier Co Ltd:Says signed exclusive license contract with sub-licenses right with a Tokyo-based company regarding the company's gene delivery technology.Says the Tokyo-based company engaged in research and development of pharmaceuticals by using drug delivery system.  Full Article

NanoCarrier announces patent assessment in U.S for substance patent on gene carrier
Tuesday, 12 Jan 2016 09:30pm EST 

NanoCarrier Co Ltd:Announced patent assessment for patent application of substance patent on gene carrier by United States Patent and Trademark Office.  Full Article

NanoCarrier announces patent assessment in Japan for NC-6004
Tuesday, 12 Jan 2016 01:00am EST 

NanoCarrier Co Ltd:Announced patent assessment for patent application of NC-6004 nano platinum by Japanese Patent Office.  Full Article

NanoCarrier announces commencement of phase I clinical trial for NC-6004 in Taiwan
Wednesday, 23 Dec 2015 09:30pm EST 

NanoCarrier Co Ltd:Says phase I clinical trial of NC-6004 nano cisplatin that developed by the company and Taiwan-based company Orient Europharma Co.,Ltd (OEP), was filed by OEP on TFDA (Taiwan Food and Drug Administration) on Dec. 16 (local time).Says the clinical trial is for investigation of tolerance safety of NC 6004, when combined with FU 5, cetuximab, as well as recommended dose of NC 6004.  Full Article

More From Around the Web

BRIEF-NanoCarrier forms cooperation with TPG Biologics Inc. on joint research

* Says the co formed cooperation with TPG Biologics Inc., a unit of Taiwan-based firm Center Laboratories Inc., on joint research